Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.32 |
| ▸ | AXL | P30530 | 1/20 | 0.31 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161716 | 0.80 | NOS2 (0.33) | AXLNUDT1 | |
| SCHEMBL5471703 | 0.72 | NISCH (0.35) | NISCHADRA2AADRA2BADRA2C | |
| SCHEMBL15088134 | 0.68 | GRIN2D (0.33) | — | |
| SCHEMBL902843 | 0.68 | NISCH (0.36) | NISCHADRA2AADRA2BADRA2CMAOA | |
| SCHEMBL7835774 | 0.67 | — | — | |
| SCHEMBL516458 | 0.64 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL30643348 | 0.64 | ITGB2 (0.37) | — | |
| SCHEMBL31408049 | 0.64 | MEN1 (0.32) | — | |
| SCHEMBL1938638 | 0.64 | CYP1A2 (0.31) | — | |
| SCHEMBL14989970 | 0.64 | AXL (0.32) | AXLNUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1988009783-A1 | POLYMERIC ULTRAVIOLET LIGHT ABSORBERS | BIOPOLYMERS LIMITED (AU) | 1988-12-15 | — | — | WO | claimed |
| US-4009271-A | 6-AZA-3H-1,4-BENZODIAZEPINES | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-02-22 | — | — | US | claimed |
| US-6313176-B1 | SELECTING AN IRREVERSIBLE ENZYME INHIBITOR AS A MEDICAMENT THAT IS METABOLIZED INTO AN UNWANTED OR ADVERSIVE METABOLITE; PLACING IRREVERSIBLE ENZYME INHIBITOR IN A SUITABLE FORMULATION; ADMINISTERING FORMULATION FOR THERAPY | ELLINWOOD JR EVERETT J (US) | 2001-11-06 | — | — | US | disclosed |
| US-6140323-A | SELECTING DRUG; PLACING FOR INHALATION OR SKIN ADMINISTRATION FORMAULATION; ADMINISTERING FORMULATION SO AS TO BYPASS GASTROINTESTINAL ABSORPTION AND PORTAL VEIN ENTRY TO LIVER TO DECREASE FORMATION OF UNWANTED METABOLITE | ELLINWOOD JR EVERETT H (US) | 2000-10-31 | — | — | US | disclosed |
| US-6048857-A | TRIFLUOROBENZODIAZEPINE | ELLINWOOD JR EVERETT H (US) | 2000-04-11 | — | — | US | disclosed |
| US-5739136-A | BUCCAL OR SUBLINGUAL DRUG DELIVERY TO BYPASS INTESTINAL METABOLISM WHICH WOULD FORM ADVERSE METABOLITES OF THE DRUG; SIDE EFFECT REDUCTION | ELLINWOOD JR EVERETT H (US) | 1998-04-14 | — | — | US | disclosed |
| US-5504086-A | MAXIMIZING ANTIANXIETY, ANTICONVULSANT AND/OR HYPNOTIC EFFECTS; HUMAN CENTRAL NERVOUS SYSTEM; SIDE EFFECT REDUCTION | ELLINWOOD JR EVERETT H (US) | 1996-04-02 | — | — | US | disclosed |
| US-5354780-A | Reduce anxiety and convulsions | ELLINWOOD EVERETT H (US) | 1994-10-11 | — | — | US | disclosed |
| US-5198436-A | Administering by mouth medicine for central nervous systems | ELLINWOOD JR EVERETT H (US) | 1993-03-30 | — | — | US | disclosed |
| WO-1988009783-A1 | POLYMERIC ULTRAVIOLET LIGHT ABSORBERS | BIOPOLYMERS LIMITED (AU) | 1988-12-15 | — | — | WO | disclosed |
| US-RE31071-E | 6-Aza-3H-1,4-benzodiazepines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1982-11-02 | — | — | US | disclosed |
| US-RE31071-E | 6-Aza-3H-1,4-benzodiazepines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1982-11-02 | — | — | US | disclosed |
| US-4009271-A | 6-AZA-3H-1,4-BENZODIAZEPINES | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-02-22 | — | — | US | disclosed |
| US-4009271-A | 6-AZA-3H-1,4-BENZODIAZEPINES | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-02-22 | — | — | US | disclosed |
| US-4008223-A | SPASMOLYTIC, ANTIPHLOGISTIC, TRANQUILIZER | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-02-15 | — | — | US | disclosed |
| US-4008223-A | SPASMOLYTIC, ANTIPHLOGISTIC, TRANQUILIZER | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-02-15 | — | — | US | disclosed |
| US-3941775-A | 6-Aza-3H-1,4-benzodiazepines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-03-02 | — | — | US | disclosed |
| US-3941775-A | 6-Aza-3H-1,4-benzodiazepines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-03-02 | — | — | US | disclosed |
| US-3917629-A | Certain 2-oxy-5-phenyl-6-aza-7-chloro-1,2-dihydro-3H-1,4-benzodiazepines | DEGUSSA | 1975-11-04 | — | — | US | disclosed |